Mitigation of radiation-induced damage by targeting EGFR in noncancerous human epithelial cells

Radiation Research

Volumn 180, Issue 3, 2013, Pages 259-267

  Kim, Sang Bum ^a   Ly, Peter ^a   Kaisani, Aadil ^a   Zhang, Lu ^a   Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CAVEOLIN 1; ERLOTINIB; HISTONE H2AX; METHYL 2 CYANO 3,12 DIOXOOLEAN 1,9 DIENE 28 OATE; PROTEIN KINASE C; RADIOPROTECTIVE AGENT; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ARTICLE; BRONCHUS MUCOSA; CELL NUCLEUS; CELL STRAIN MCF 7; CELL VIABILITY; CELLULAR DISTRIBUTION; COLON CANCER; CYTOPLASM; DNA DAMAGE; DNA REPAIR; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION INJURY; RADIATION PROTECTION;

BRONCHI; CELL LINE, TUMOR; CELLS, CULTURED; COLON; DNA DAMAGE; DNA REPAIR; EPITHELIAL CELLS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84884244023     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3371.1     Document Type: Article

References (36)

1. Szumiel I. Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. Cell Signal 2006; 18:1537-1548.
2. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002; 62:7350-7356.
3. Golding SE, Morgan RN, Adams BR, Hawkins AJ, Povirk LF, Valerie K. Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther 2009; 8:730-738.
4. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85.
5. Dittmann K, Mayer C, Kehlbach R, Rodemann HP. Radiationinduced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer 2008; 7:69.
6. Dittmann K, Mayer C, Rodemann HP. Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol 2010; 186:1-6.
7. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 2005; 280:31182-31189.
8. Bandyopadhyay D, Mandal M, Adam L, Mendelsohn J, Kumar R. Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J Biol Chem 1998; 273:1568-1573.
9. Das AK, Chen BP, Story MD, Sato M, Minna JD, Chen DJ, et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res 2007; 67:5267-5274.
10. Zips D, Krause M, Yaromina A, Dorfler A, Eicheler W, Schutze C, et al. Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results. J Pharm Pharmacol 2008; 60:1019-1028.
11. Dittmann K, Mayer C, Rodemann HP. Inhibition of radiationinduced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol 2005; 76:157-161.
12. Thimmulappa RK, Fuchs RJ, Malhotra D, Scollick C, Traore K, Bream JH, et al. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxid Redox Signal 2007; 9:1963-1970.
13. Petronelli A, Pannitteri G, Testa U. Triterpenoids as new promising anticancer drugs. Anticancer Drugs 2009; 20:880-892.
14. Vannini N, Lorusso G, Cammarota R, Barberis M, Noonan DM, Sporn MB, et al. The synthetic oleanane triterpenoid, CDDOmethyl ester, is a potent antiangiogenic agent. Mol Cancer Ther 2007; 6:3139-3146.
15. Deeb D, Gao X, Liu Y, Jiang D, Divine DW, Arbab AS, et al. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis 2011; 32:757-764.
16. Liby KT, Royce DB, Risingsong R, Williams CR, Maitra A, Hruban RH, et al. Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer Prev Res (Phila) 2010; 3:1427-1434.
17. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 2011.
18. Eskiocak U, Kim SB, Roig AI, Kitten E, Batten K, Cornelius C, et al. CDDO-Me protects against space radiation-induced transformation of human colonic epithelial cells. Radiat Res 2010; 173:27-36.
19. Roig AI, Eskiocak U, High SK, Kim SB, Delgado O. Souza RF, et al. Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology 2010; 138:1012-1021.
20. Gerweck LE, Dullea R, Zaidi ST, Budach W, Hartford A. Influence of experimental factors on intrinsic radiosensitivity assays at low doses of radiation: cell multiplicity. Radiat Res 1994; 138:361-366.
21. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1:2315-2319.
22. Roig AI, Hight SK, Shay JW. Two-and three-dimensional models for risk assessment of radiation-enhanced colorectal tumorigenesis. Radiat Res 2009; 171:33-40.
23. Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 2006; 1:23-29.
24. Chen DC, Nirodi CS. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res 2007; 13:6555-6560.
25. Kim SB, Pandita RK, Eskiocak U, Ly P, Kaisani A, Kumar R, et al. Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation. Proc Natl Acad Sci USA 2012; 109:E2949-2955.
26. Peus, Vasa RA, Meves A, Beyerle A, Pittelkow MR. UVBinduced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 2000; 72:135-140.
27. Gao X, Deeb D, Hao J, Liu Y, Arbab AS, Dulchavsky SA, et al. Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-fkappagB signaling proteins in colorectal cancer cells. Anticancer Res 2010; 30:785-792.
28. Deeb D, Gao X, Arbab AS, Barton K, Dulchavsky SA, Gautam SC. CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer. Cancers (Basel) 2010; 2:1779-1793.
29. Shibata T, Kokubu S, Gotoh M, Ojima H, Ohta T, Yamamoto M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008; 135:1358-1368, 1368 e1351-1354.
30. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008; 68:1303-1309.
31. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 2008; 105:13568-13573.
32. Andreassen CN, Grau C, Lindegaard JC. Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol 2003; 13:62-72.
33. Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999; 17:3333-55.
34. Bhattacharjee Y. Devastation in Japan. Candidate radiation drugs inch forward. Science 2011; 331:1505.
35. Shay JW, Cucinotta FA, Sulzman FM, Coleman CN, Minna JD. From Mice and Men to Earth and Space: Joint NASA-NCI Workshop on Lung Cancer Risk Resulting from Space and Terrestrial Radiation. Cancer Res 2011; 71:6926-9.
36. Durante D, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 2008; 8:465-472.